These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19105897)

  • 1. Molecular aspects of mucoadhesive carrier development for drug delivery and improved absorption.
    Peppas NA; Thomas JB; McGinty J
    J Biomater Sci Polym Ed; 2009; 20(1):1-20. PubMed ID: 19105897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
    Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
    Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface design of nanocarriers: Key to more efficient oral drug delivery systems.
    Spleis H; Sandmeier M; Claus V; Bernkop-Schnürch A
    Adv Colloid Interface Sci; 2023 Mar; 313():102848. PubMed ID: 36780780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advance in oral delivery systems for therapeutic protein.
    He S; Liu Z; Xu D
    J Drug Target; 2019 Mar; 27(3):283-291. PubMed ID: 29952664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarrier systems for oral drug delivery: do we really need them?
    Bernkop-Schnürch A
    Eur J Pharm Sci; 2013 May; 49(2):272-7. PubMed ID: 23537503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents.
    Serra L; Doménech J; Peppas NA
    Eur J Pharm Biopharm; 2009 Mar; 71(3):519-28. PubMed ID: 18976706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering the Mucus Barrier.
    Carlson TL; Lock JY; Carrier RL
    Annu Rev Biomed Eng; 2018 Jun; 20():197-220. PubMed ID: 29865871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
    Okur NÜ; Siafaka PI; Gökçe EH
    Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucoadhesive carriers for oral drug delivery.
    Kumar R; Islam T; Nurunnabi M
    J Control Release; 2022 Nov; 351():504-559. PubMed ID: 36116580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral bioavailability and drug/carrier particulate systems].
    Wawrezinieck A; Péan JM; Wüthrich P; Benoit JP
    Med Sci (Paris); 2008; 24(6-7):659-64. PubMed ID: 18601886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs.
    Wang Y; Pi C; Feng X; Hou Y; Zhao L; Wei Y
    Int J Nanomedicine; 2020; 15():6295-6310. PubMed ID: 32943863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
    He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
    Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
    Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
    Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
    Lehr CM
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.
    Maisel K; Ensign L; Reddy M; Cone R; Hanes J
    J Control Release; 2015 Jan; 197():48-57. PubMed ID: 25449804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of mucoadhesive polymers in nasal drug delivery.
    Jiang L; Gao L; Wang X; Tang L; Ma J
    Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems.
    Subramanian DA; Langer R; Traverso G
    J Nanobiotechnology; 2022 Aug; 20(1):362. PubMed ID: 35933341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ gelling and mucoadhesive polymers: why do they need each other?
    Zahir-Jouzdani F; Wolf JD; Atyabi F; Bernkop-Schnürch A
    Expert Opin Drug Deliv; 2018 Oct; 15(10):1007-1019. PubMed ID: 30173567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
    Silva AC; Santos D; Ferreira D; Lopes CM
    Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.